Human Adipose-Derived Mesenchymal Stem Cells

Human Adipose-Derived Mesenchymal Stem Cells

$725.00

Cryopreserved vial of human adipose-derived mesenchymal stem cells (~500,000 cells)

SKU: CR1004-500 Categories: ,

Product Overview

Cells derived from adult human lipoaspirate tissue collected during elective surgical liposuction procedures and then programmed using our patented virus-free method using episomal DNA and our proprietary mix of vectors, excluding Myc and Lin28 transcription factors. Adipose-derived mesenchymal cells (AdMSCs) are the most commonly used mesenchymal stem cells for clinical applications.

The cell line was validated for pluripotency based on colony morphology, alkaline phosphatase expression and expression of SSEA-4. Cells are free of Mycloplasma and exhibit classical morphology and growth characteristics. Vial contains approximately 500,000 cells. Shipped with dry ice.

AdMSCs have shown significant promise in treating autoimmune and neurodegenerative diseases, vascular and metabolic diseases, bone and cartilage regeneration and wound defects. These cells have been reported to differentiate into many different lineages including chondrogenic, osteogenic, adipogenic and neural cells.

Technical Specification

Coming Soon

Stability & Storage

Temperature 
 Storage Time
Human Adipose-Derived Mesenchymal Stem Cells
-80°C
(preferably in the vapor phase of a liquid nitrogen storage unit)
12 months
Human Mesenchymal Stem Cell Expansion Media (not included)
4°C
3 months
Human Chondrogenic Differentiation Media (not included)
4°C
3 months
Complete Media (see Media Formulation Instructions)
2-8°C
Not applicable
Avoid repeated freeze-thaw cycles for cells. Avoid repeated exposure to room temperature and light for media.

Publications

Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells.
Chu, KA et al. | International Journal of Molecular Sciences 2023 APR.

Exosomes derived from human adipose-derived stem cells alleviate hepatic ischemia-reperfusion (I/R) injury through the miR-183/ALOX5 axis.
Gong, Y et al. | FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 2023 MAR.